6533b836fe1ef96bd12a0872

RESEARCH PRODUCT

Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations

Olga KisterCarmil AzranArik DahanMoran ZurPeter LangguthOmri WolkDavid CzeigerNoa Fine-shamirGad ShakedGilbert Sebbag

subject

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismPublic Health Environmental and Occupational HealthSevere obesity030226 pharmacology & pharmacyEffective solutionSurgery03 medical and health sciences0302 clinical medicinemedicineMedical team030212 general & internal medicinebusinessOral retinoid

description

Bariatric surgery is the most effective solution for severe obesity and obesity with comorbidities, and the number of patients going through bariatric surgery is rapidly and constantly growing. The modified gastrointestinal anatomy of the patient may lead to significant pharmacokinetic alterations in the oral absorption of drugs after the surgery; however, because of insufficient available literature and inadequate awareness of the medical team, bariatric surgery patients may be discharged from the hospital with insufficient instructions regarding their medication therapy. In this article, we aim to present the various mechanisms by which bariatric surgery may influence oral drug absorption, to provide an overview of the currently available literature on the subject, and to draw guidelines for the recommendations bariatric surgery patients should be instructed before leaving the hospital. To date, and until more robust data are published, it is essential to follow and monitor patients closely for safety and efficacy of their medication therapies, both in the immediate and distant time post-surgery.

https://doi.org/10.1111/obr.12434